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Interim Guidance for Environmental Infection 
Control in Hospitals for Ebola Virus
On August 1, 2014, CDC released guidance titled,”Infection Prevention and Control 
Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in 
U.S. Hospitals(http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-
recommendations.html).”
Ebola viruses are transmitted through direct contact with blood or body fluids/substances (e.g., 
urine, feces, vomit) of an infected person with symptoms or through exposure to objects (such as 
needles) that have been contaminated with infected blood or body fluids. The role of the 
environment in transmission has not been established. Limited laboratory studies under favorable 
conditions indicate that Ebolavirus can remain viable on solid surfaces, with concentrations falling 
slowly over several days.1, 2 In the only study to assess contamination of the patient care 
environment during an outbreak, virus was not detected in any of 33 samples collected from sites 
that were not visibly bloody. However, virus was detected on a blood-stained glove and bloody 
intravenous insertion site.3 There is no epidemiologic evidence of Ebolavirus transmission via 
either the environment or fomites that could become contaminated during patient care (e.g., bed 
rails, door knobs, laundry). However, given the apparent low infectious dose, potential of high virus 
titers in the blood of ill patients, and disease severity, higher levels of precaution are warranted to 
reduce the potential risk posed by contaminated surfaces in the patient care environment.
As part of the care of patients who are persons under investigation, or with probable or confirmed 
Ebola virus infections(http://www.cdc.gov/vhf/ebola/hcp/case-definition.html), hospitals are 
recommended to:
Be sure environmental services staff wear recommended personal protective 
equipment (PPE)(http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html) to protect 
against direct skin and mucous membrane exposure of cleaning chemicals, 
contamination, and splashes or spatters during environmental cleaning and 
disinfection activities. If reusable heavy-duty gloves are used for cleaning and 
disinfecting, they should be disinfected and kept in the room or anteroom. Be sure staff are 
instructed in the proper use of personal protective equipment including safe removal to 
prevent contaminating themselves or others in the process, and that contaminated 
equipment is disposed of appropriately. (see question 8).
Use a U.S. Environmental Protection Agency (EPA)-registered hospital disinfectant 
with a label claim for a non-enveloped virus (e.g., norovirus, rotavirus, adenovirus, 
poliovirus) to disinfect environmental surfaces in rooms of patients with suspected 
or confirmed Ebola virus infection. Although there are no products with specific label 
claims against the Ebola virus, enveloped viruses such as Ebola are susceptible to a broad 
range of hospital disinfectants used to disinfect hard, non-porous surfaces. In contrast, non-
enveloped viruses are more resistant to disinfectants. As a precaution, selection of a 
disinfectant product with a higher potency than what is normally required for an enveloped 
virus is being recommended at this time. EPA-registered hospital disinfectants with label 
claims against non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) are 
broadly antiviral and capable of inactivating both enveloped and non-enveloped viruses.
Avoid contamination of reusable porous surfaces that cannot be made single use. 
Use only a mattress and pillow with plastic or other covering that fluids cannot get through. 
Do not place patients with suspected or confirmed Ebola virus infection in carpeted rooms 
and remove all upholstered furniture and decorative curtains from patient rooms before use.
To reduce exposure among staff to potentially contaminated textiles (cloth products) 
while laundering, discard all linens, non-fluid-impermeable pillows or mattresses, 
and textile privacy curtains into the waste stream and disposed of appropriately.
The Ebola virus is a classified as a Category A infectious substance by and regulated 
by the U.S. Department of Transportation’s (DOT) Hazardous Materials Regulations 
(HMR, 49 C.F.R., Parts 171-180). Any item transported offsite for disposal that is 
contaminated or suspected of being contaminated with a Category A infectious 
substance must be packaged and transported in accordance with the HMR. This 
includes medical equipment, sharps, linens, and used health care products (such as 
soiled absorbent pads or dressings, kidney-shaped emesis pans, portable toilets, 
used Personal Protection Equipment (gowns, masks, gloves, goggles, face shields, 
respirators, booties, etc.) or byproducts of cleaning) contaminated or suspected of 
being contaminated with a Category A infectious substance.6, 7 (see question 8).
Frequently Asked Questions
1. How can I determine whether a particular EPA-registered hospital 
disinfectant is appropriate for use in the room of a patient with suspected or 
confirmed Ebola virus infection?
Begin by looking at the product label or product insert or, if these are not available, search the EPA 
search engine for this information. Users should be aware that an 'enveloped' or 'non-enveloped 
virus' designation may not be included on the container label. Instead check the disinfectant's label 
for at least one of the common non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, 
poliovirus).
2. Are there special instructions for cleaning and disinfecting the room of a 
patient with suspected or confirmed Ebola virus infection?
Daily cleaning and disinfection of hard, non-porous surfaces (e.g., high-touch surfaces such as bed 
rails and over bed tables, housekeeping surfaces such as floors and counters) should be done.4 
Before disinfecting a surface, cleaning should be performed. In contrast to disinfection where 
products with specific claims are used, any cleaning product can be used for cleaning tasks. Use 
cleaning and disinfecting products according to label instructions. Check the disinfectant's label for 
specific instructions for inactivation of any of the non-enveloped viruses (e.g., norovirus, rotavirus, 
adenovirus, poliovirus) follow label instructions for use of the product that are specific for 
inactivation of that virus. Use disposable cleaning cloths, mop cloths, and wipes and dispose of 
these in leak-proof bags. Use a rigid waste receptacle designed to support the bag to help 
minimize contamination of the bag's exterior.
3. How should spills of blood or other body substances be managed?
The basic principles for blood or body substance spill management are outlined in the United 
States Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen Standards 
(29 CFR 1910.1030).5 CDC guidelines recommend removal of bulk spill matter, cleaning the site, 
and then disinfecting the site.4 For large spills, a chemical disinfectant with sufficient potency is 
needed to overcome the tendency of proteins in blood and other body substances to neutralize the 
disinfectant's active ingredient. An EPA-registered hospital disinfectant with label claims for non-
enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) and instructions for cleaning 
and decontaminating surfaces or objects soiled with blood or body fluids should be used according 
to those instructions.
4. How should disposable materials (e.g., any single-use PPE, cleaning cloths, 
wipes, single-use microfiber cloths, linens, food service) and linens, privacy 
curtains, and other textiles be managed after their use in the patient room?
These materials should be placed in leak-proof containment and discarded appropriately. To 
minimize contamination of the exterior of the waste bag, place this bag in a rigid waste receptacle 
designed for this use. Incineration or autoclaving as a waste treatment process is effective in 
eliminating viral infectivity and provides waste minimization. If disposal requires transport offsite 
then this should be done in accordance with the U.S. Department of Transportation’s (DOT) 
Hazardous Materials Regulations (HMR, 49 C.F.R., Parts 171-180).6, 7 Guidance from DOT has 
been released for Ebola.7
5. Is it safe for Ebola patients to use the bathroom?
Yes. Sanitary sewers may be used for the safe disposal of patient waste. Additionally, sewage 
handling processes (e.g., anaerobic digestion, composting, and disinfection) in the United States 
are designed to inactivate infectious agents.
6. How long does the Ebola virus persist in indoor environments?
Only one laboratory study, which was done under environmental conditions that favor virus 
persistence, has been reported. This study found that under these ideal conditions Ebola virus 
could remain active for up to six days.1 In a follow up study, Ebolavirus was found, relative to other 
enveloped viruses, to be quite sensitive to inactivation by ultraviolet light and drying; yet sub-
populations did persist in organic debris.2
In the only study to assess contamination of the patient care environment during an outbreak, 
conducted in an African hospital under "real world conditions", virus was not detected by either 
nucleic acid amplification or culture in any of 33 samples collected from sites that were not visibly 
bloody. Virus was detected on a blood-stained glove and bloody intravenous insertion site by 
nucleic acid amplification, which may detect non-viable virus, but not by culture for live, infectious 
virus.3 Based upon these data and what is known regarding the environmental infection control of 
other enveloped RNA viruses, the expectation is with consistent daily cleaning and disinfection 
practices in U.S. hospitals that the persistence of Ebola virus in the patient care environment would 
be short – with 24 hours considered a cautious upper limit.
7. Are wastes generated during delivery of care to Ebola virus-infected patients 
subject to select agent regulations?
As long as facilities treating Ebola virus-infected patients follow the CDC's Infection Prevention and 
Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic 
Fever in U.S. Hospitals(http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-
recommendations.html); waste generated during delivery of care to Ebola virus-infected patients 
would not be subject to Federal select agent regulations (See the exclusion provision 42 CFR § 
73.3(d)(1)). However, this would not apply to any facility that intentionally collected or otherwise 
extracted the Ebola virus from waste generated during the delivery of patient care.
8. Are wastes generated during delivery of care to Ebola virus-infected patients 
subject to any special transportation requirements?
Yes, wastes contaminated or suspected to be contaminated with Ebola virus must be packaged 
and transported in accordance U.S. DOT Hazardous Materials Regulations (HMR, 49 C.F.R., Parts 
171-180).6, 7
Once a patient with suspected Ebola Virus Disease (e.g., Patients under investigation) is no longer 
suspected to have Ebola Virus disease (EVD) or has ruled out for EVD, their waste materials no 
longer need to be managed as if contaminated with Ebola Virus.
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